worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Products

Novartis Products

Pharmaceuticals

Innovating to treat disease more effectively

Our global Pharmaceuticals portfolio includes more than 50 key marketed products, many of which are innovative leaders in their therapeutic areas. In 2009 we received a total of 25 positive regulatory decisions in the United States, Europe and Japan.

Key pharmaceutical products marketed by Novartis are listed below by therapeutic area.

Not all products or indications are available in all countries. Regulatory requirements in various countries limit the product information that we can provide. Please consult your physician about any medical condition or prescription product.

Note that some product links are intended for US residents only.


A-Z

A C D E F G I L M N P R S T V X Z

 

 

Elidel (pimecrolimus)

  • Atopic dermatitis (eczema)

Enablex/Emselex (darifenacin)

  • Overactive bladder

Combipatch/Estalis/Estalis Sequi (estradiol hemihydrate)

  • Treatment of signs and symptoms of estrogen deficiency due to the menopause
  • Prevention of accelerated postmenopausal bone loss

Estraderm TTS/Estraderm MX (estradiol hemihydrate)

  • Treatment of signs and symptoms of estrogen deficiency due to the menopause
  • Prevention of accelerated postmenopausal bone loss

Vivelle Dot/Estradot (estradiol hemihydrate)

  • Estrogen replacement therapy for the treatment of the symptoms of menopause
  • Prevention of postmenopausal osteoporosis

Estragest TTS Sequidot (estradiol hemihydrate and norethisterone acetate)

  • Treatment of symptoms of estrogen deficiency in postmenopausal women with an intact uterus
  • Prevention of postmenopausal osteoporosis in women with an intact uterus

Eucreas (vildagliptin and metformin)

  • Type 2 diabetes

Exelon & Exelon Patch (rivastigmine tartrate & rivastigmine transdermal system)

  • Alzheimer’s disease
  • Dementia associated with Parkinson’s disease

Exforge (valsartan and amlodipine besylate)

  • Hypertension

Exforge HCT (valsartan, amlodipine besylate and hydrochlorothiazide)

  • Hypertension

Exjade (deferasirox)

  • Chronic iron overload due to blood transfusions

Extavia (interferon beta-1b)

  • Single demyelinating event with active inflammatory processes and relapsing forms of Multiple Sclerosis

 

Back to top

Pharmaceuticals business at Novartis

Novartis discovers and develops innovative medicines with improved efficacy and fewer side-effects.

Latest news

Patient groups

Patient groups

Our commitment to high-quality healthcare has led to an enduring and trusted partnership between Novartis and various patient groups.